titers of positive sera in prostatic cancer patients were similar to those in sera of bladder cancer patients and of non-cancerous individuals. . . . . . . .
The occurrence of SV40-neutralizing antibodies in sera of patients with genitourinary carcinoma
β Scribed by Keerti V. Shah; Loreto D. Palma; Gerald P. Murphy
- Publisher
- John Wiley and Sons
- Year
- 1971
- Tongue
- English
- Weight
- 398 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Neutralizing antibodies to simian virus 40 (SV40) were detected in sera of seven of 182 patients studied a t the Roswell Park Memorial Institute. Four of 91 (4.4%) bladder tumor patients, two of 24 (8.3%) patients with prostatic carcinoma, and one of four patients with testicular tumors had antibodies. Neutralizing antibodies were demonstrable in repeated bleedings over a 5-11 month period. T antibodies were not detected in any of the sera. None of the antibody-positive patients gave a history of immunization with (potentially SV40-contaminated) poliovirus vaccines, the only known source of major human exposure to SV40 in the United States. These findings suggest that the seven antibody-positive donors were infected with a virus cross-reacting with SV40 or that infection with SV40 may have occurred in some unknown manner.
π SIMILAR VOLUMES
Studies of immune recognition in cancer have defined several tumor antigens using autologous cytotoxic T lymphocytes and by detection of serum antibodies to tumor-associated products such as p53 and HER-2/neu. The AIS gene is a p53 homologue with multiple protein products (p40, p51, p63, p73L) on ch
Sera obtained from fifty-five patients with active systemic lupus erythematosus (SLE) and from four patients with mixed connective tissue disease (MCTD) previously shown by immunofluorescence and by double immunodiffusion to possess antinuclear antibodies, were tested for the presence of natural ant
## Abstract Examination of anticardiolipin antibodies (ACAs) in the sera of patients clinically diagnosed with chronic fatigue syndrome (CFS) using an enzymeβlinked immunoassay procedure demonstrated the presence of immunoglobulin M isotypes in 95% of CFS serum samples tested. The presence of immun